Participant Articles: Non-WashU

Scientists are searching for the secret in Doug Whitney’s biology that has protected him from dementia, hoping it could lead to ways to treat or prevent Alzheimer’s for many other people.

Among members of the Richardson family who carry a mutation in the PSEN1 gene, the average age when symptoms start is 39

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from the brains of people destined to develop Alzheimer’s dementia can delay the disease.

Clinical trial of people destined to develop early-onset Alzheimer’s disease shows eliminating amyloid from brain may prevent symptoms, supports need for confirmatory studies

Some antiamyloids remove target plaques from the brain, yet don’t seem to halt cognitive decline. Researchers are working to understand why.

Andres Martin, a 31-year-old Marine, is being treated at Walter Reed National Military Medical Center for a rare form of Alzheimer’s disease that impacts people with roots in Jalisco, Mexico. He worries his daughter, Alexis, who is not yet 2, will also have it.

A devastating disease that can rob you of your memory has an Alabama woman traveling to Missouri for help. The mother of three is taking part in a ground breaking study led by Washington University. Carrie Richardson, a 34-year-old preschool teacher and mother of three is in the fight of her life.